131 related articles for article (PubMed ID: 10965934)
21. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
[TBL] [Abstract][Full Text] [Related]
22. Serum cytokines levels in Graves' disease.
Al-Humaidi MA
Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
[TBL] [Abstract][Full Text] [Related]
23. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
Lacka K; Manuszewska E; Korczowska I; Lacki JK
Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949
[TBL] [Abstract][Full Text] [Related]
24. Detectable serum IgE levels in Graves' ophthalmopathy.
Molnár I; Horváth S; Balázs C
Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
[TBL] [Abstract][Full Text] [Related]
25. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
26. Glucose and insulin metabolism in patients with hyperthyroidism due to Graves' disease.
Mano T; Kawakubo A; Yamamoto M
Nagoya J Med Sci; 1994 Mar; 57(1-4):61-8. PubMed ID: 7898563
[TBL] [Abstract][Full Text] [Related]
27. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D
J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519
[TBL] [Abstract][Full Text] [Related]
28. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N
Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498
[TBL] [Abstract][Full Text] [Related]
29. Increased serum neopterin levels in patients with Graves' disease.
Wagner R; Hayatghebi S; Rosenkranz M; Reinwein D
Exp Clin Endocrinol; 1993; 101(4):249-54. PubMed ID: 8307114
[TBL] [Abstract][Full Text] [Related]
30. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
31. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy.
Kahaly GJ; Pitz S; Hommel G; Dittmar M
J Clin Endocrinol Metab; 2005 Sep; 90(9):5234-40. PubMed ID: 15998777
[TBL] [Abstract][Full Text] [Related]
32. Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy.
Wichary H; Gasińska T
Thyroid; 2012 Jan; 22(1):64-9. PubMed ID: 22029719
[TBL] [Abstract][Full Text] [Related]
33. Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.
Akarsu E; Buyukhatipoglu H; Aktaran S; Kurtul N
Clin Endocrinol (Oxf); 2011 Jan; 74(1):118-24. PubMed ID: 21044110
[TBL] [Abstract][Full Text] [Related]
34. Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism.
Wahrenberg H; Wennlund A; Hoffstedt J
Eur J Endocrinol; 2002 May; 146(5):607-11. PubMed ID: 11980614
[TBL] [Abstract][Full Text] [Related]
35. Plasma filtration in the treatment of Graves' ophthalmopathy: A randomized study.
Cap J; Ceeova V; Skacha M; Rezek P; Vlcek P; Blaha M
J Clin Apher; 2010; 25(4):209-15. PubMed ID: 20818716
[TBL] [Abstract][Full Text] [Related]
36. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
[TBL] [Abstract][Full Text] [Related]
37. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
Macchia PE; Bagattini M; Lupoli G; Vitale M; Vitale G; Fenzi G
J Endocrinol Invest; 2001 Mar; 24(3):152-8. PubMed ID: 11314743
[TBL] [Abstract][Full Text] [Related]
38. Impairment of prednisolone disposition in patients with Graves' disease taking methimazole.
Legler UF
J Clin Endocrinol Metab; 1988 Jan; 66(1):221-3. PubMed ID: 3335606
[TBL] [Abstract][Full Text] [Related]
39. Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.
Moleti M; Giuffrida G; Sturniolo G; Squadrito G; Campennì A; Morelli S; Puxeddu E; Sisti E; Trimarchi F; Vermiglio F; Marinò M
Endocrine; 2016 Oct; 54(1):259-268. PubMed ID: 27003434
[TBL] [Abstract][Full Text] [Related]
40. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Jpn J Ophthalmol; 2002; 46(5):563-7. PubMed ID: 12457917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
